| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 Mar 2026 | 6 Mar 2026 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/03/2026 inter alia to consider and approve and evaluate the proposal for raising of funds by way of issuance of equity shares in one or more tranches by way of one or more Qualified Institutions Placements (QIP) and/or rights issue in accordance with the applicable provisions of the Companies Act 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations 2018 (each as amended) or through any other permissible mode or any combination thereof in such manner and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion subject to the receipt of necessary approvals including the approval of the members of the Company and such other regulatory and statutory approvals as may be required if any as may be required and determination of the issue price. Outcome of the meeting of the Board of Directors of Krishna Institute of Medical Sciences Limited (the Company) held on 11th March, 2026, in terms of the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR Regulations). (As Per BSE Announcement Dated on: 11/03/2026) | ||
| Board Meeting | 6 Feb 2026 | 2 Feb 2026 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 ,inter alia, to consider and approve the unaudited (Standalone & Consolidated) financial results of the company for the 03rd quarter and nine-months ended December 31, 2025 Outcome of Board Meeting Q3FY26 (As Per BSE Announcement Dated on: 06/02/2026) | ||
| Board Meeting | 7 Nov 2025 | 24 Oct 2025 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve the unaudited (Standalone & Consolidated) financial results of the company for the 02nd quarter and half-year ended September 30 2025. Results (As Per BSE Announcement Dated on 07.11.2025) | ||
| Board Meeting | 6 Aug 2025 | 24 Jul 2025 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 inter alia to consider and approve the unaudited (Standalone & Consolidated) financial results of the company for the 01st quarter ended June 30 2025. Outcome of Board Meeting Results for Q1FY26 (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 12 May 2025 | 2 May 2025 |
| Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Board Meeting Intimation Outcome of Board Meeting (As Per BSE Announcement Dated on: 12/05/2025) | ||
Here are some of the stocks that may see significant price movement today: GIC Re, GSK Pharma, Godfrey Philips, etc.
It has entered into a share purchase agreement to acquire a 100% equity stake in Chalasani Hospitals Pvt Ltd.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
